Phase III, randomized, double-blind, multicenter, placebo (P)-controlled trial of rilotumumab (R) plus epirubicin, cisplatin and capecitabine (ECX) as first-line therapy in patients (pts) with advanced MET-positive (pos) gastric or gastroesophageal junction (G/GEJ) cancer: RILOMET-1 study [abstract]
We are the global leader in online prescription drug savings with almost 20 years of experience supplying prescription and over the counter drugs to our international customers
Further research is needed to establish a comprehensive understanding of DSIPs safety profile and to provide clear guidelines for its responsible use
We have very professional agents in Europe, Australia, the United States, Canada, Mexico and other places
First isolated in the 1970s from the cerebral venous blood of sleeping rabbits, DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide whose biology has fascinated and puzzled neuroscientists for half a century
